Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10 clinical trials
Sulodexide VESSEL for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

The study aims at optimizing extended management of elderly patients (> 75 years) with at least one of the known bleeding risk factor, who suffered from first episode of venous thromboembolism of the lower extremity (proximal deep vein thrombosis with or without pulmonary embolism) (VTE). Patients were randomized to receive …

abuse
embolism
antiplatelet therapy
thrombosis
thrombocytopenia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study

Patients who have suffered a stroke are having an increased risk of having recurrent stroke in the future. This risk of stroke is increased by atrial fibrillation, which often "comes and goes" (called paroxysmal) and hence escapes routine diagnostics. The hypothesis of Find-AF 2 is that enhanced (evaluation in a …

embolism
holter monitor
deficit
atrial fibrillation
stroke
  • 0 views
  • 05 Aug, 2020
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and …

embolism
thrombosis
pulmonary embolism
lung diseases
anticoagulation treatment
  • 0 views
  • 16 Feb, 2024
  • 31 locations
Acute Atrial Fibrillation and Flutter Treated Electively

All patients who have not received adequate anticoagulation for three weeks prior to the delayed cardioversion will undergo a transesophageal cardiac ultrasound to ensure they are not in excess risk for thromboembolic events. Patients randomized to elective treatment have the possibility to opt-out and undergo acute cardioversion if their symptoms …

fibrillation
arrhythmia
thromboembolism
antiarrhythmic drug
cardioversion
  • 0 views
  • 16 Feb, 2024
  • 4 locations
Post-marketing Surveillance of EVRENZO Tablets (Roxadustat) in Dialysis-dependent Patients With Renal Anemia

The purpose of this study is to assess the safety and efficacy, including the incidence of thromboembolism, in renal anemia patients on dialysis treated with roxadustat (EVRENZO Tablets) in actual clinical settings.

dialysis
anemia
  • 0 views
  • 05 Aug, 2020
Aspirin Thromboprophylaxis After First-line Total Hip and Knee Replacement (TBP-ASPIR)  

A recent publication suggests that the risk of bleeding is currently greater than the risk of a thromboembolic event. More recently, foreign or international recommendations have broadened the range of these recommendations, notably by introducing aspirin as a possible prophylactic agent.

  • 0 views
  • 02 Sep, 2022
  • 5 locations
Effect of Blood Group on the Survival Status of Intensive Care Patients

The research was planned to determine the effect of different blood groups on the 90-day survival of intensive care patients who were treated and maintained for the first time in the intensive care unit. The research is a retrospective descriptive research. For the first time in an intensive care unit …

  • 0 views
  • 05 Aug, 2020
Thromboembolic Events in Severe COVID-19 Patients

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive …

covid-19
acute respiratory syndrome (sars)
haemostasis
thromboembolism
  • 0 views
  • 16 Feb, 2024
  • 1 location
Sequelae of Sars-CoV-2 Infections

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the …

cardiovascular system
coronavirus infection
pneumonia
acute respiratory syndrome (sars)
  • 0 views
  • 16 Feb, 2024
  • 1 location
Echocardiographic Predictors of Atrial Fibrillation

This prospective study aims to identify the diagnostic accuracy of echocardiographic predictors of atrial fibrillation in patients with ESUS (embolic stroke of undetermined source) or TIA (transient ischemic attack).

infarct
embolism
stenosis
ischemia
hypercoagulability
  • 0 views
  • 19 Sep, 2021
  • 1 location